Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyruvate kinase activators for use in treating blood disorders

Pyruvate kinase activators for use in treating blood disorders

US Patent 11364240 · Granted Jun 21, 2022

Estimated economic value: $12,689,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

KRas inhibitors2025
Carrier for olefin polymerization catalyst, and preparation method therefor and 2025
Water-soluble ynamide coupling reagent and preparation method and use thereof2024
Heterocyclic compounds and uses thereof2024
Substituted benzamides as RIPK2 inhibitors for treatment of inflammatory bowel d2024
Pyruvate kinase activators for use in treating blood disorders2024
Pyruvate kinase activators for use in treating blood disorders2024
Pyruvate kinase activators for use in treating blood disorders2024
Pyruvate kinase activators for use in treating blood disorders2024
Pyruvate kinase activators for use in treating blood disorders2024
Pyruvate kinase activators for use in treating blood disorders2024
Pyruvate kinase activators for use in treating blood disorders2024